JANE STREET GROUP, LLC - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 162 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2016. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$2,000
-98.6%
21,083
-73.6%
0.00%
Q2 2018$139,000
+63.5%
80,000
+73.0%
0.00%
Q1 2018$85,000
-24.1%
46,232
-8.1%
0.00%
Q4 2017$112,000
-81.6%
50,287
-76.0%
0.00%
-100.0%
Q3 2017$608,000
+371.3%
209,676
+623.2%
0.00%
Q2 2017$129,000
-39.4%
28,991
-25.0%
0.00%
-100.0%
Q3 2016$213,000
-36.4%
38,660
-38.8%
0.00%
-50.0%
Q3 2015$335,000
-47.3%
63,128
-17.7%
0.00%
-50.0%
Q2 2015$636,000
+1225.0%
76,676
+544.3%
0.00%
+300.0%
Q2 2014$48,000
-58.3%
11,900
-45.2%
0.00%0.0%
Q1 2014$115,00021,7080.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q4 2016
NameSharesValueWeighting ↓
Nantahala Capital Management 11,578,568$20,147,0000.82%
Virtus ETF Advisers LLC 441,461$768,0000.68%
Hikari Power Ltd 2,300,000$4,002,0000.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,403,149$2,441,0000.17%
KNOTT DAVID M 225,400$392,0000.15%
Clear Harbor Asset Management, LLC 277,110$482,0000.09%
Malaga Cove Capital, LLC 97,264$169,0000.09%
Lehman Financial Resources, Inc. 80,800$140,0000.07%
Cheyne Capital Management (UK) LLP 50,000$87,0000.06%
Ballew Advisors, Inc 26,200$46,0000.05%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders